Ganglioside GD2, Human (Naxitamab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-Ganglioside GD2, Human (Naxitamab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Ganglioside GD2, Human (Naxitamab biosimilar) |
| Clone | Naxitamab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG1 kappa |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human Ganglioside GD2 Recombinant Antibody (Naxitamab). Naxitamab, sold under the brand name Danyelza, is an anti-cancer medication. It is a monoclonal antibody used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) for people one year of age and older with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow demonstrating a partial response, minor response, or stable disease to prior therapy. |
| Immunogen | n/a |
| Other Names | Anti-Ganglioside GD2 Recombinant Antibody, Research Grade Naxitamab, Anti-Human Ganglioside GD2 Recombinant Antibody(Naxitamab), Hu3F8, Antibody Drug Analogues, Monoclonal Antibody, YR1539, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 1879925-92-4 |
| Catalog # | YR1539 |
| Price | please inquire |
| Order / More Info | Ganglioside GD2, Human (Naxitamab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies